Pregnant Women Turning To Safer Antiseizure Drugs
By Dennis Thompson HealthDay Reporter
THURSDAY, July 24, 2025 — More pregnant women are turning to newer and potentially safer antiseizure medications, a new study says.
Older antiseizure drugs like valproate and phenobarbital are known to increase risk of birth defects.
But there’s been a 30% increase in the use of the safest antiseizure drugs during pregnancy, researchers report in the July 23 issue of Neurology.
“The good news is that use of the drugs with the greatest risks has decreased, and use of the safest drugs has increased, but we are concerned to still see use during pregnancy of some drugs with known risks and new drugs with uncertain risk,” senior researcher Dr. Rosemary Dray-Spira said in a news release. Dray-Spira is deputy director of the French National Agency for the Safety of Medicines and Health Products.
For the study, researchers analyzed more than 55,800 pregnancies in France between 2013 and 2021 in which the mother took at least one antiseizure medication.
“These medications can be used for epilepsy, mood disorders, chronic pain and migraine, which often occur at young ages, and sometimes people are taking them before they realize that they are pregnant,” Dray-Spira said.
Researchers placed the drugs in three safety categories:
-
Safest – lamotrigine and levetiracetam.
-
Uncertain risk – pregabalin, gabapentin, lacosamide and zonisamide.
-
Known risk – valproic acid, valpromide, carbamazepine and topiramate.
Use of the safest drugs increased by 30% during the study period, researchers found.
At the same time, use of valproic acid and valpromide decreased by more than 80%.
Exposure to the risky drugs carbamazepine and topiramate barely changed.
Researchers also found a 28% increase in use of the new drugs pregabalin and gabapentin, despite their uncertain risks, and exposure to these newer drugs increased over time.
“Despite a sharp shift from valproate to safer antiseizure medications, prenatal exposure to other ASMs with acknowledged or uncertain risks has persisted or even increased,” researchers concluded.
This study comes on the heels of another Neurology report earlier this month, which found that levetiracetam, oxcarbazepine, gabapentin and zonisamide do not show an increased risk for birth defects.
The July 16 report also confirmed that valproate, phenobarbital and topiramate increase the odds of major birth defects in infants.
Sources
- American Academy of Neurology, news release, July 23, 2025
- Neurology, July 23, 2025
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Some Newer Antiseizure Meds Safer During Pregnancy
THURSDAY, July 17, 2025 — Some newer antiseizure medications appear to be safer for pregnant women to take without risk of birth defects, a new study...
Popular Chronic Pain Med, Gabapentin, Linked To Dementia Risk
FRIDAY, July 11, 2025 — A drug used to treat seizures, nerve pain and restless leg syndrome might be linked with increased risk of dementia, a new study says. Regular...
Schools Should Be Prepared For These Three Medical Emergencies
THURSDAY, July 3, 2025 — There are three common health emergencies for which all U.S. schools should be prepared, a new study says. Brain-related crises like seizures...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.